A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination

Summary

To describe the safety during days 0 to 21 following injection of the 2003-2004 formulation of the inactivated, split-virion influenza vaccine Fluzone® in subjects aged 18-59 years and subjects aged ≥ 60 years. To describe the immune response at 21 days following injection of the 2003-2004 formulation of the inactivated, split-virion influenza vaccine Fluzone®, in subjects aged 18-59 years and subjects aged ≥ 60 years.

Timeline

Start

2003-07

Primary completion

2003-09

Completion

2003-09

Drugs

Indications